Position
Quantbot Technologies LP in Royalty Pharma PLC
Back to the book · All holders of RPRX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $267.6K$38.64 → $47.97
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 104.1K | $4.02M | — | — | — | 0.1% |
| Q1 2026 | 28.7K | $1.38M | $47.97 | $267.6K | −$2.91M | 0.1% |